Furthermore, in HCC patients, high expression of SKA1 and SKA2 was notably associated with shorter overall survival, while high expression of the Ska protein complex was markedly associated with shorter disease-free survival. The gene discussed is SKA2; the disease is hepatocellular carcinoma.